Similar to pharmaceutical modeling, most cancer models start by modeling normal bone homeostasis and supplement it with an equation for tumor dynamics . Many cancer models also add or adjust parameters such as RANKL, TGF-β, and PTH, which are known to be modified by tumors. The populations of these cancer tumor cells (T) are usually modeled in one of two ways. The first modeling method is based on growth curves, as in